Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Image-Guided Neurologics (IGN) was a medical technology company specializing in the development of advanced navigation and delivery systems for minimally invasive neurosurgery. The company's flagship product, the Navigus system, provided a skull-mounted trajectory guide that allowed neurosurgeons to precisely target deep brain structures using real-time imaging. IGN's technology was primarily utilized in deep brain stimulation (DBS) procedures for treating movement disorders such as Parkinson's disease and essential tremor. Following its acquisition by Medtronic in 2005, IGN's innovations were integrated into Medtronic's industry-leading neuromodulation and surgical navigation portfolios. The acquisition strengthened Medtronic's position in the neuro-navigation market and expanded its offerings for functional neurosurgery.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Image-Guided Neurologics.